Meet Lan Huang

Q&A with Huang, PhD, Molecular & Cellular Proteomics associate editor who uses crosslinking mass spec to study protein–protein interactions.

BrightFocus Foundation Awards Nearly $13M to 50 Scientists for Alzheimer’s, Macular Degeneration, and Glaucoma Research

Dorota Skowronska-Krawczyk, PhD, is one of the National Glaucoma Research grant recipients.

Study aims to identify at-risk individuals before onset of Alzheimer’s disease

Researchers hope to identify some of the earliest changes in the Alzheimer's disease brain to help identify at-risk individuals, including people previously excluded from current therapies.

Key enzyme in lipid metabolism linked to immune system aging

Decreased activity of the enzyme ELOVL2 accelerates white blood cell aging and alters the expression of cancer-associated genes, new research suggests.

UC Irvine School of Medicine Reaches Semifinals of STAT Madness

UC Irvine School of Medicine’s research team has made it through to the Semifinals of STAT Madness, an annual competition by STAT that brings together the best biomedical research from the past year. Research from institutions across the country face off against each other in a bracket-style matchup in which votes determine the winner.

Nuclear speckles identified as key hubs for gene expression regulation

UCI researchers, including Yongsheng Shi, PhD, professor in the Department of Microbiology and Molecular Genetics, and first author Yoseop Yoon, PhD, uncover the critical role of nuclear speckles as the major site of pre-mRNA 3' end processing.

UC Irvine-co-led Study Finds DNA Damage is Key Factor in Age-related Macular Degeneration

A research team co-led by the University of California, Irvine has discovered that accumulated DNA damage in the retina is a key contributor to age-related macular degeneration and that targeting specific retinal cell types may lead to treatments that slow or stop progression.

UC Irvine researchers are first to reveal role of ophthalmic acid in motor function control

A research team from the University of California, Irvine is the first to reveal that a molecule in the brain — ophthalmic acid — unexpectedly acts like a neurotransmitter similar to dopamine in regulating motor function, offering a new therapeutic target for Parkinson’s and other movement diseases.

UC Irvine receives initial $33 million in federal support for vaccine research

Philip Felgner, PhD, professor in residence in the Department of Physiology & Biophysics, and director of UC Irvine’s Adeline Yen Mah Vaccine Center, will lead a multi-institutional pandemic planning effort with this $33 million grant from the National Institute of Allergy and Infectious Diseases.

UCI School of Medicine's PhD Orientation 2024

UCI School of Medicine welcomes 36 incoming PhD students for the 2024-2025 academic year.